UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
A concise guide to spotting tax-friendly dividend ETFs, including key metrics and quick tips to boost after-tax performance.
22,830 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Vertiv rode a powerful wave in February as AI-driven data-center demand accelerated and the company highlighted durab...
Federal regulators are moving to expand Fed master account access for crypto firms, a shift TD Cowen says banks canno...
A high-profile lawsuit raises questions about payout rules and regulatory oversight in prediction markets. This artic...
Tensions in the Strait of Hormuz have intensified, with ships stalled and crude prices rising. The ripple effects tou...
Oracle has a booming backlog that signals future revenue, but it also requires massive spending. This article breaks ...
Atlassian shares remain under pressure as the company drives cost cuts and pivots to a cloud-focused model. Analysts ...
IBM stock slides as Anthropic's AI code tool threatens IBM's COBOL modernization business, forcing investors to repri...
Chase has cut credit-card limits for some customers with minimal usage, raising questions about credit-score impact a...
A seasoned investor at Benchmark warns that the AI boom may be inflating prices beyond fundamentals, signaling a comi...
Fortune Brands Innovations stunned investors with a leadership overhaul after a zero-day CEO exit yielded $18.4 milli...
Discover how nyxoah (nyxh) 2025 earnings could shape an investor's view of MedTech plays. This forward-looking analys...